Literature DB >> 23929545

Abnormalities in white matter microstructure associated with chronic ketamine use.

R Edward Roberts1, H Valerie Curran1, Karl J Friston2, Celia J A Morgan3.   

Abstract

Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist that has been found to induce schizophrenia-type symptoms in humans and is a potent and fast-acting antidepressant. It is also a relatively widespread drug of abuse, particularly in China and the UK. Acute administration has been well characterized, but the effect of extended periods of ketamine use-on brain structure in humans-remains poorly understood. We measured indices of white matter microstructural integrity and connectivity in the brain of 16 ketamine users and 16 poly-drug-using controls, and we used probabilistic tractography to quantify changes in corticosubcortical connectivity associated with ketamine use. We found a reduction in the axial diffusivity profile of white matter in a right hemisphere network of white matter regions in ketamine users compared with controls. Within the ketamine-user group, we found a significant positive association between the connectivity profile between the caudate nucleus and the lateral prefrontal cortex and dissociative experiences. These findings suggest that chronic ketamine use may be associated with widespread disruption of white matter integrity, and white matter pathways between subcortical and prefrontal cortical areas may in part predict individual differences in dissociative experiences due to ketamine use.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23929545      PMCID: PMC3870785          DOI: 10.1038/npp.2013.195

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  44 in total

1.  Nonparametric permutation tests for functional neuroimaging: a primer with examples.

Authors:  Thomas E Nichols; Andrew P Holmes
Journal:  Hum Brain Mapp       Date:  2002-01       Impact factor: 5.038

Review 2.  The basis of anisotropic water diffusion in the nervous system - a technical review.

Authors:  Christian Beaulieu
Journal:  NMR Biomed       Date:  2002 Nov-Dec       Impact factor: 4.044

3.  Reduction of eddy-current-induced distortion in diffusion MRI using a twice-refocused spin echo.

Authors:  T G Reese; O Heid; R M Weisskoff; V J Wedeen
Journal:  Magn Reson Med       Date:  2003-01       Impact factor: 4.668

Review 4.  Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex.

Authors:  Rita Z Goldstein; Nora D Volkow
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

5.  Subanaesthetic ketamine treatment alters prefrontal cortex connectivity with thalamus and ascending subcortical systems.

Authors:  Neil Dawson; Brian J Morris; Judith A Pratt
Journal:  Schizophr Bull       Date:  2011-11-22       Impact factor: 9.306

6.  Investigation of anatomical thalamo-cortical connectivity and FMRI activation in schizophrenia.

Authors:  Stefano Marenco; Jason L Stein; Antonina A Savostyanova; Fabio Sambataro; Hao-Yang Tan; Aaron L Goldman; Beth A Verchinski; Alan S Barnett; Dwight Dickinson; José A Apud; Joseph H Callicott; Andreas Meyer-Lindenberg; Daniel R Weinberger
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 7.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 8.  Fast robust automated brain extraction.

Authors:  Stephen M Smith
Journal:  Hum Brain Mapp       Date:  2002-11       Impact factor: 5.038

9.  Abnormal brain structure implicated in stimulant drug addiction.

Authors:  Karen D Ersche; P Simon Jones; Guy B Williams; Abigail J Turton; Trevor W Robbins; Edward T Bullmore
Journal:  Science       Date:  2012-02-03       Impact factor: 47.728

10.  Investigating cervical spinal cord structure using axial diffusion tensor imaging.

Authors:  Claudia A M Wheeler-Kingshott; Simon J Hickman; Geoffrey J M Parker; Olga Ciccarelli; Mark R Symms; David H Miller; Gareth J Barker
Journal:  Neuroimage       Date:  2002-05       Impact factor: 6.556

View more
  17 in total

1.  Preliminary analysis of positive and negative syndrome scale in ketamine-associated psychosis in comparison with schizophrenia.

Authors:  Ke Xu; John H Krystal; Yuping Ning; Da Chun Chen; Hongbo He; Daping Wang; Xiaoyin Ke; Xifan Zhang; Yi Ding; Yuping Liu; Ralitza Gueorguieva; Zuoheng Wang; Diana Limoncelli; Robert H Pietrzak; Ismene L Petrakis; Xiangyang Zhang; Ni Fan
Journal:  J Psychiatr Res       Date:  2014-12-24       Impact factor: 4.791

2.  Ketamine metabolite pilot study in a suicidal depression trial.

Authors:  Michael F Grunebaum; Hanga C Galfalvy; Tse-Hwei Choo; Michelle S Parris; Ainsley K Burke; Raymond F Suckow; Thomas B Cooper; J John Mann
Journal:  J Psychiatr Res       Date:  2019-08-09       Impact factor: 4.791

3.  Neurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trial.

Authors:  James W Murrough; Katherine E Burdick; Cara F Levitch; Andrew M Perez; Jess W Brallier; Lee C Chang; Alexandra Foulkes; Dennis S Charney; Sanjay J Mathew; Dan V Iosifescu
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

Authors:  Leah Vines; Diana Sotelo; Allison Johnson; Evan Dennis; Peter Manza; Nora D Volkow; Gene-Jack Wang
Journal:  Intell Med       Date:  2022-03-07

5.  Effects of early ketamine exposure on cerebral gray matter volume and functional connectivity.

Authors:  Chia-Chun Hung; Yi-Hsuan Liu; Chu-Chung Huang; Cheng-Ying Chou; Chun-Ming Chen; Jeng-Ren Duann; Chiang-Shan R Li; Tony Szu-Hsien Lee; Ching-Po Lin
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

Review 6.  Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research.

Authors:  André Schmidt; Vaibhav A Diwadkar; Renata Smieskova; Fabienne Harrisberger; Undine E Lang; Philip McGuire; Paolo Fusar-Poli; Stefan Borgwardt
Journal:  Front Hum Neurosci       Date:  2015-01-13       Impact factor: 3.169

7.  Efficacy of ketamine in the rapid treatment of major depressive disorder: a meta-analysis of randomized, double-blind, placebo-controlled studies.

Authors:  Yu Han; Jianjun Chen; Dezhi Zou; Peng Zheng; Qi Li; Haiyang Wang; Pengfei Li; Xinyu Zhou; Yuqing Zhang; Yiyun Liu; Peng Xie
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-03       Impact factor: 2.570

8.  Chronic administration of ketamine induces cognitive deterioration by restraining synaptic signaling.

Authors:  Yayan Luo; Yang Yu; Minling Zhang; Hongbo He; Ni Fan
Journal:  Mol Psychiatry       Date:  2020-06-02       Impact factor: 15.992

Review 9.  Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.

Authors:  Ronald S Duman
Journal:  Dialogues Clin Neurosci       Date:  2014-03       Impact factor: 5.986

Review 10.  Practical application of the neuroregenerative properties of ketamine: real world treatment experience.

Authors:  Theodore A Henderson
Journal:  Neural Regen Res       Date:  2016-02       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.